Compare McKesson Corporation (MCK) vs Reddit Inc (RDDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Reddit Inc — how do they compare? McKesson Corporation trades at $824.45 (market cap $97.35B), while Reddit Inc trades at $184.57 (market cap $34.97B). The key difference: McKesson Corporation is far larger — about 2.8× Reddit Inc's market cap, and McKesson Corporation pays a 0.39% dividend while Reddit Inc pays none. Which is the better fit depends on your goals.
| MCK | RDDT | |
|---|---|---|
Market Cap | $97.35B | $34.97B |
Sector | Health | Media |
52-Week High | $995.69 | $270.71 |
52-Week Low | $659.01 | $121.84 |
Enterprise Value | $101.98B | $32.22B |
Dividend Yield | 0.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.
The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.
Reddit (RDDT) trades at $181.67, showing modest daily gains of 0.21%. The stock faces bearish technical signals with key support at $178 and resistance at $184. Fundamentally, the company demonstrates strong profitability with 91.37% gross margins and 28.6% net income margin, though valuation ratios remain elevated with a P/E of 51.77. Recent earnings show mixed results with a Q3 2025 miss but subsequent beats, while Q2 2026 results are pending.
The investment outlook balances strong fundamental growth against high valuation and technical headwinds. Analyst consensus remains bullish with a $236.89 price target (62.96% buy ratings), but risks include competitive pressures in digital advertising and execution challenges in AI initiatives. The stock offers growth potential but requires careful monitoring of upcoming earnings and market sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Reddit Inc
Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →
